Previous Article | Next Article ![]()
Infect. Immun., Apr 1996, 1181-1189, Vol 64, No. 4
JY Channon and LH Kasper
The ability of Toxoplasma gondii to evade the host immune response during
primary infection in humans is poorly understood. In murine toxoplasmosis,
infected spleen macrophages release soluble factors that mediate a
transient immunosuppression, which may allow the parasite to become
established. When an enriched population of human monocytes from
seronegative individuals was incubated with toxoplasmas in vitro, soluble
factors that mediated market suppression of mitogen-induced lymphocyte DNA
synthesis were released. Irradiated tachyzoites that do not undergo
replication were sufficient stimuli for near-maximal soluble factor
release. Up to 50% of the soluble factor-mediated suppression is
attributable to a gamma interferon (IFN-gamma)-dependent pathway, and the
mediator of the remaining inhibition is neither interleukin-10,
transforming growth factor beta, prostaglandin E2, lipoxygenase products,
nitric oxide, nor tumor necrosis factor alpha- induced mitochondrial
cell-derived reactive oxygen intermediates. IFN- gamma also mediates the
up-regulation of an antigen-presenting cell phenotype by both infected and
uninfected macrophages. However, IFN- gamma does not activate macrophages
to become toxoplasmacidal; instead, intracellular toxoplasmas replicate and
reinfect, eventually lysing the macrophage population. These results
suggest that T. gondii is able to evade the naive host immune response by
induction of soluble immunosuppressive factors that allow the parasite to
become established during an acute infection.
Copyright © 1996, American Society for Microbiology
Toxoplasma gondii-induced immune suppression by human peripheral blood monocytes: role of gamma interferon
Department of Microbiology, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|